These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 20544806)
1. The cynomolgus monkey as a model for developmental toxicity studies: variability of pregnancy losses, statistical power estimates, and group size considerations. Jarvis P; Srivastav S; Vogelwedde E; Stewart J; Mitchard T; Weinbauer GF Birth Defects Res B Dev Reprod Toxicol; 2010 Jun; 89(3):175-87. PubMed ID: 20544806 [TBL] [Abstract][Full Text] [Related]
2. Development in the cynomolgus macaque following administration of ustekinumab, a human anti-IL-12/23p40 monoclonal antibody, during pregnancy and lactation. Martin PL; Sachs C; Imai N; Tsusaki H; Oneda S; Jiao Q; Treacy G Birth Defects Res B Dev Reprod Toxicol; 2010 Oct; 89(5):351-63. PubMed ID: 20540088 [TBL] [Abstract][Full Text] [Related]
4. Developmental toxicity testing of monoclonal antibodies: an enhanced pre- and postnatal study design option. Stewart J Reprod Toxicol; 2009 Sep; 28(2):220-5. PubMed ID: 19379807 [TBL] [Abstract][Full Text] [Related]
5. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats. Weisenburger WP; Hagler AR; Tassinari MS Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738 [TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
8. Pre- and postnatal development in the cynomolgus monkey following administration of ABT-874, a human anti-IL-12/23p40 monoclonal antibody. Enright BP; Tornesi B; Weinbauer GF; Blaich G Birth Defects Res B Dev Reprod Toxicol; 2012 Dec; 95(6):431-43. PubMed ID: 23212752 [TBL] [Abstract][Full Text] [Related]
9. Embryotoxicity studies of norfloxacin in cynomolgus monkeys: I. Teratology studies and norfloxacin plasma concentration in pregnant and nonpregnant monkeys. Cukierski MA; Prahalada S; Zacchei AG; Peter CP; Rodgers JD; Hess DL; Cukierski MJ; Tarantal AF; Nyland T; Robertson RT Teratology; 1989 Jan; 39(1):39-52. PubMed ID: 2718139 [TBL] [Abstract][Full Text] [Related]
10. The enhanced pre- and postnatal development study for monoclonal antibodies. Weinbauer GF; Luft J; Fuchs A Methods Mol Biol; 2013; 947():185-200. PubMed ID: 23138905 [TBL] [Abstract][Full Text] [Related]
11. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis). Hendrickx AG; Hummler H Teratology; 1992 Jan; 45(1):65-74. PubMed ID: 1731397 [TBL] [Abstract][Full Text] [Related]
12. Use of barusiban in a novel study design for evaluation of tocolytic agents in pregnant and neonatal monkeys, including behavioural and immunological endpoints. Rasmussen AD; Nelson JK; Chellman GJ; Golub M; McAnulty PA Reprod Toxicol; 2007 Jun; 23(4):471-9. PubMed ID: 17337159 [TBL] [Abstract][Full Text] [Related]
13. Object discrimination reversal as a method to assess cognitive impairment in nonhuman primate enhanced pre- and postnatal developmental (ePPND) studies: statistical power analysis. Cappon GD; Bowman CJ; Hurtt ME; Grantham LE Birth Defects Res B Dev Reprod Toxicol; 2012 Oct; 95(5):354-62. PubMed ID: 22930561 [TBL] [Abstract][Full Text] [Related]
14. The enhanced pre- and postnatal study for nonhuman primates: update and perspectives. Weinbauer GF; Fuchs A; Niehaus M; Luetjens CM Birth Defects Res C Embryo Today; 2011 Dec; 93(4):324-33. PubMed ID: 22271681 [TBL] [Abstract][Full Text] [Related]
15. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring. Chung MK; Kim CY; Kim JC Cancer Chemother Pharmacol; 2007 Feb; 59(3):383-95. PubMed ID: 16896929 [TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Dimethyl Methylphosphonate (CAS No. 756-79-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1987 Nov; 323():1-172. PubMed ID: 12748730 [TBL] [Abstract][Full Text] [Related]
17. Assessment of ixekizumab, an interleukin-17A monoclonal antibody, for potential effects on reproduction and development, including immune system function, in cynomolgus monkeys. Clarke DO; Hilbish KG; Waters DG; Newcomb DL; Chellman GJ Reprod Toxicol; 2015 Dec; 58():160-73. PubMed ID: 26482726 [TBL] [Abstract][Full Text] [Related]
18. The role of maternal toxicity in lovastatin-induced developmental toxicity. Lankas GR; Cukierski MA; Wise LD Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):111-23. PubMed ID: 15282732 [TBL] [Abstract][Full Text] [Related]
19. Conduct and interpretation of a dermal developmental toxicity study with KBR 3023 (a prospective insect repellent) in the Sprague-Dawley rat and Himalayan rabbit. Astroff AB; Young AD; Holzum B; Sangha GK; Thyssen JH Teratology; 2000 Mar; 61(3):222-30. PubMed ID: 10661912 [TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity studies of methacrylonitrile (CAS No. 126-98-7). Administered by gavage to F344/N rats and B6C3F1 mice. Ghanayem BI Toxic Rep Ser; 2000 May; (47):1-56, A1-E6. PubMed ID: 11803706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]